AGM
CBMG

Alpine Global Management’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Alpine Global Management’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-119,902
Closed -$2.2M – 421
2020
Q4 		$2.2M Buy
119,902
+94,902
+380% +$1.73M 0.45% 36
2020
Q3 		$459K Buy
+25,000
New +$420K 0.1% 114

Alpine Global Management's CBMG Position: Q1 2021 in Review

Alpine Global Management sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 119,902 shares — an estimated $2.2M sold.

Alpine Global Management first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $2.2M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Alpine Global Management reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Alpine Global Management sold 119,902 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $2.2M.
  • Alpine Global Management first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
  • Alpine Global Management's Cellular Biomedicine Group, Inc. position peaked at $2.2M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Alpine Global Management's 13F filing for Q1 2021, filed 13 May 2021.